Highest-materiality recent filing
Colgate-Palmolive annual meeting: all 10 directors elected, say-on-pay approved
All 10 director nominees elected with votes for ranging from 580.9M to 630.7M.
Colgate Q1: net sales +8.4%, organic +2.9%; GAAP EPS $0.80 (-6%), base EPS $0.97 (+7%)
Net sales $5.324B (+8.4%), organic sales +2.9%; global toothpaste share 41.1% year-to-date.
Colgate-Palmolive names Betsy Fishbone as new Chief Legal Officer effective June 1, 2026
Jennifer M. Daniels, CLO & Secretary since 2014, plans to retire in 2026.
Colgate-Palmolive realigns segments effective Q1 2026; creates new EMEA segment
Europe and Africa/Eurasia (ex-Russia/Belarus) plus Skin Health from North America form new Europe, Middle East & Africa segment.
Colgate-Palmolive adds BMY CEO Boerner to board; director Cahillane to leave in May
Christopher S. Boerner (Bristol-Myers Squibb CEO) elected to Board, effective March 15, 2026.
Colgate-Palmolive FY2025 revenue +1.4% to $20.4B; GAAP EPS $2.63, down 25% on impairment
Full year net sales $20,382M (+1.4%); organic sales growth +1.4% after -0.7% impact from lower private label pet volume.
Colgate-Palmolive issues €600M 3.250% Senior Notes due 2035
€600 million aggregate principal amount of 3.250% Senior Notes due 2035 issued on November 10, 2025.
Colgate-Palmolive Q3 net sales up 2% to $5.13B, EPS $0.91; announces $200-300M restructuring program
Net sales $5.13B (+2% YoY); organic sales +0.4% reflecting exit of non-strategic pet business.
Colgate Q2 EPS $0.91, organic sales +1.8%; approves $200-300M productivity plan
Net sales $5,110M (+1.0%); organic sales +1.8% including -0.6% from lower private label pet sales.
Colgate-Palmolive appoints Shane Grant as COO Americas; Parameswaran retires
Shane Grant, former Danone Deputy CEO, appointed COO Americas from June 16, 2025.
Colgate annual meeting elects directors, approves auditor, rejects proposals
All 10 director nominees elected, including CEO Noel Wallace who received 580.9M votes for.
Colgate-Palmolive issues $500M of 4.200% Senior Notes due 2030
Issued $500M aggregate principal amount of 4.200% Senior Notes due 2030 on May 2, 2025.
Colgate Q1 net sales -3.1% to $4.91B; organic sales +1.4%; GAAP EPS $0.85 (+2%)
Net sales $4,911M, down 3.1% YoY; organic sales +1.4% (incl. -0.4% from private label pet).
Colgate FY 2024 sales top $20B for first time; EPS up 27%; organic sales +7.4%
Net sales $20.1B, up 3.3% YoY; organic sales growth 7.4% despite 0.5% negative impact from private label pet volume.
Net sales $5,033M (+2.4%), organic sales +6.8%; GAAP EPS $0.90 (+5%), Base Business EPS $0.91 (+6%).
Net sales $5,033M (+2.4% YoY); organic sales +6.8%; GAAP EPS $0.90 (+5%); Base Business EPS $0.91 (+6%).
Colgate Q2 net sales up 4.9%, organic +9.0%; GAAP EPS $0.89 (+48%)
Net sales $5.058B, +4.9% YoY; organic sales growth +9.0%.
All 10 director nominees elected; Noel R. Wallace received 593.7M votes for (lowest), 46.1M against, 6.7M abstentions.
Colgate Q1 net sales +6.2% to $5.07B; GAAP EPS $0.83 (+84%); raises FY guidance
Net sales $5,065M (+6.2% YoY); organic sales +9.8%.
Colgate elects UPS CFO Brian Newman to board; Sadove to retire at May 2024 meeting
Brian Newman, EVP and CFO of UPS, elected to Colgate board effective March 15, 2024.
Colgate-Palmolive FY 2023 net sales +8.5%; GAAP EPS $2.77 (+30%)
Full-year 2023 net sales $19.5B, +8.5%; organic sales also +8.5%.
Colgate-Palmolive Q3 2023: EPS $0.86 (+16% YoY), organic sales +9%, raises FY guidance
Net sales $4,915M, up 10.5%; organic sales +9.0% with growth in five out of six divisions.
Colgate-Palmolive Board renews Executive Severance Plan with 3-year term and non-compete requirement
Plan renewed on September 13, 2023 for three years, subject to automatic one-year extensions unless Board decides otherwise.
Director Michael B. Polk resigns from Colgate-Palmolive board for personal reasons
Michael B. Polk resigned from Colgate-Palmolive's Board of Directors on August 18, 2023, citing personal reasons.
Colgate reports Q2 GAAP EPS down 17% to $0.60; Base Business EPS up 7% to $0.77
Net sales $4,822M (+7.5% YoY); organic sales +8.0% with growth in every division.
All 11 director nominees elected; support ranged from 85.3% (Lorrie Norrington) to 99.0% (Steve Cahillane).
Colgate Q1 net sales +8.5% to $4.77B; GAAP EPS drops 32% to $0.45; guidance updated
Net sales $4,770M (+8.5% YoY); organic sales +10.0% with growth in every division and category.
Colgate-Palmolive issues $1.5B in senior notes across three tranches
Issued $500M 4.800% Senior Notes due 2026, $500M 4.600% due 2028, and $500M 4.600% due 2033.
Colgate-Palmolive elects Kellogg CEO Steven Cahillane to its Board
Steven Cahillane, Chairman and CEO of Kellogg Company, elected to Colgate Board, effective Feb 1, 2023.
Colgate Q4 organic sales +8.5%; GAAP EPS $2.13 (-16%) on Filorga impairment
Q4 net sales +5.0%, organic sales +8.5%, with growth in every division and category.
Board approved by-law amendments effective January 12, 2023.
Colgate Q3 net sales +1% to $4.455B; organic +7%; EPS down 9% on FX
Net sales $4.455B (+1% YoY); organic sales growth 7% across all divisions and categories.
Colgate-Palmolive closes $1.5B senior notes offering (3.100% 2025, 2027; 3.250% 2032)
Completed offering of $500M of 3.100% Senior Notes due 2025, $500M of 3.100% due 2027, and $500M of 3.250% due 2032.
Colgate-Palmolive prices $1.5B senior notes in three tranches due 2025, 2027, 2032
Issued $500M 3.100% Senior Notes due 2025, $500M 3.100% Notes due 2027, and $500M 3.250% Notes due 2032.
Colgate-Palmolive Q2 EPS falls 13% to $0.72; organic sales up 9%, guidance raised to 5-7%
Net sales $4.48B, up 5.5% YoY; organic sales growth 9.0% with gains in all divisions and categories.
Gregory Malcolm elected Vice President and Controller, effective June 30, 2022, serving as principal accounting officer.
Colgate-Palmolive announces 2022 annual meeting voting results; all director nominees elected
All 10 director nominees elected; Noel R. Wallace received 579M for, 66M against.
Colgate Q1 net sales up 1.5%, organic sales +4%; GAAP EPS $0.66 down 18% YoY
Net sales $4.399B (+1.5% YoY); organic sales growth 4.0%.
Colgate-Palmolive board adopts policy limiting executive cash severance to 2.99x compensation
Board approved policy capping new cash severance at 2.99x base salary plus target bonus, effective April 8, 2022.
Full year net sales $17.42B (+6.0% YoY); organic sales growth +4.5%.
Colgate-Palmolive lowers special meeting threshold to 15% from 25% after shareholder proposal
Shareholder proposal to lower threshold to 10% received 50.56% support at 2021 annual meeting.
Colgate-Palmolive completes €500M 0.300% Senior Notes offering due 2029
Issued €500M aggregate principal of 0.300% Senior Notes due 2029 on Nov 10, 2021.
Colgate-Palmolive issues €500M of 0.300% Senior Notes due 2029
€500 million aggregate principal of 0.300% Senior Notes due 2029.
Colgate Q3 net sales +6.5%, GAAP EPS down 7% to $0.75; base EPS +3% to $0.81
Net sales $4,414M (+6.5%), organic sales growth +4.5%.
Colgate Q2 net sales up 9.5% to $4.26B; GAAP EPS $0.83 (+12%), base EPS $0.80 (+8%)
Net sales $4,260M (+9.5% YoY); organic sales growth +5.0%.
Colgate-Palmolive recommends rejecting TRC Capital mini-tender offer at $80.63/share
TRC Capital offers to buy up to 1.5M Colgate shares (0.18% of outstanding) at $80.63/share.
the Company announced that its Board of Directors (the “Board”) had elected Shane Grant as the Company’s Chief Operating Officer, Americas, reporting to Chairman, President and Chief Executive Officer, Noel R. Wallace, effective June 16, 2025.
the Board has elected Ms. Parameswaran Vice Chair of the Company, effective June 16, 2025.
The Board also approved the promotion of Panagiotis Tsourapas to the position of Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development
and John Hazlin to the position of Chief Growth Officer
has communicated to the Company her intention to retire from the Company on October 1, 2025.
Stephen I. Sadove, 72, will retire as a director at the end of his current term and will not stand for reelection to the Board at the Annual Meeting of Stockholders to be held on May 10, 2024.
elected Brian Newman, Executive Vice President and Chief Financial Officer of United Parcel Service, Inc. (“UPS”), to the Colgate Board, effective March 15, 2024.
On August 18, 2023, Michael B. Polk resigned from Colgate-Palmolive Company’s Board of Directors for personal reasons.
On January 30, 2023, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate”) elected Steven Cahillane, Chairman of the Board, President and Chief Executive Officer of Kellogg Company (“Kellogg”), to the Colgate Board, effective February 1, 2023.
Philip G. Shotts, who has served as the Company's Controller since June 2018, will continue as Senior Vice President, Finance, also effective June 30, 2022.
elected Gregory Malcolm Vice President and Controller of the Company, effective June 30, 2022.
Max materiality 0.85 · Median 0.53 · Most common event earnings